Analyst Ratings for Catalent Over the past 3 months, 8 analysts have published their opinion on Catalent (NYSE:CTLT) stock. These analysts are typically employed…
Why Catalent Stock Plummeted by Nearly 25% Today Flat revenue growth, a sharp decline in profitability, and reduced guidance combined to make an awful day for the company....…
Uber, Pfizer rise; Catalent, Stryker fall Stocks that traded heavily or had substantial price changes Tuesday: Uber, Pfizer rise; Catalent, Stryker fall...…
Catalent stock paces S&P 500 losers as it suffers record selloff after earnings miss, lowered outlook Shares of Catalent Inc. plunged 23.4% toward a record one-day selloff, and enough to pace the S&P 500's …
Catalent (CTLT) Q1 Earnings Lag Estimates, FY23 View Cut Catalent (CTLT) records robust first-quarter fiscal 2023 results of its Pharma and Consumer Health segment despite overall soft performance....…
Catalent Shares Hit 52-Week Low on Earnings Miss, Guidance Cut >CTLT Catalent Shares Hit 52-Week Low on Earnings Miss, Guidance Cut >CTLT...…
Catalent (CTLT) Q1 Earnings and Revenues Miss Estimates Catalent (CTLT) delivered earnings and revenue surprises of -38.18% and 4.01%, respectively, for the quarter ended September 2022. Do the…
Catalent breaches 52-week low, falls 25% on dismal Q3 earnings Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Catalent Q1 2023 Earnings Preview Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: Pres. Pharma Prod Delivery Div verkauft Aktien von Catalent im Wert von 72.038$ Hawkeswood, Thomas W. - Vorstand - Tag der Transaktion: 2022-10-10...…